13F Pro

SEC Form 4 reporting owner

Benzeno Sharon

Benzeno Sharon has filed 20 Form 4 transactions reported between November 20, 2025 and June 29, 2026, as Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp.

Name as filed: BENZENO SHARON

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$14.5M
5 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 29, 2026
transaction date

Roles and reported holdings

  • ADPTAdaptive Biotechnologies Corp
    Nov 20, 2025 – Jun 29, 2026

    Chief Commercial Ofc Imm Med

    Held directly221,278 sh as of Jun 29, 2026 · Form 4

    24 months: $14.5M sold

Transaction history

All 20 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 29, 2026ADPTChief Commercial Ofc Imm MedOpen-market saleCode S · direct154,768$3.3M@ $21.14Form 4
Jun 29, 2026ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct51,570$419K@ $8.12Form 4
Jun 29, 2026ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct24,944$211K@ $8.46Form 4
Jun 29, 2026ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct1,837$22K@ $12.14Form 4
Jun 26, 2026ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct11,034$134K@ $12.14Form 4
Mar 11, 2026ADPTChief Commercial Ofc Imm MedOpen-market saleCode S · direct63,103$831K@ $13.17Form 4
Mar 4, 2026ADPTChief Commercial Ofc Imm MedGrant or awardCode A · direct39,063—Form 4
Dec 4, 2025ADPTChief Commercial Ofc Imm MedOpen-market saleCode S · direct12,604$212K@ $16.85Form 4
Dec 4, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct4,157$35K@ $8.46Form 4
Dec 4, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct4,290$52K@ $12.14Form 4
Nov 21, 2025ADPTChief Commercial Ofc Imm MedOpen-market saleCode S · direct308,477$5.2M@ $16.91Form 4
Nov 21, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct83,145$332K@ $3.99Form 4
Nov 21, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct119,809$1.5M@ $12.14Form 4
Nov 21, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct34,375$250K@ $7.27Form 4
Nov 21, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct49,480$324K@ $6.55Form 4
Nov 21, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct20,834$136K@ $6.55Form 4
Nov 21, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct834$5K@ $6.27Form 4
Nov 20, 2025ADPTChief Commercial Ofc Imm MedOpen-market saleCode S · direct297,925$4.9M@ $16.54Form 4
Nov 20, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct68,961$837K@ $12.14Form 4
Nov 20, 2025ADPTChief Commercial Ofc Imm MedOption exerciseCode M · direct133,032$1.1M@ $8.46Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.